FRANKFURT (Reuters) - Swiss drugmaker Novartis said two late-stage trials showed its drug secukinumab improved symptoms of psoriatic arthritis, a type of arthritis associated with the skin disease psoriasis that causes joint pain, stiffness and swelling. The trials, which involved a total of more than 1,000 people, showed the drug improved peripheral joint disease and prevented joint damage compared with a placebo and helped clear patients' skin, Novartis said in a statement on Thursday. ...
via Health News Headlines - Yahoo News http://ift.tt/YaKx36
via Health News Headlines - Yahoo News http://ift.tt/YaKx36
No comments:
Post a Comment